Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 0

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States

Ji, Hongxiang, Zhao, Ziyi, Li, Ronghao, Ma, Wenlu, Zhang, Mimi, Zhou, Zhongyun · 2026 · Frontiers in Nutrition

Abstract

Objective: This study aims to investigate the association between the hemoglobin A1c (HbA1c)/high-density lipoprotein cholesterol (HDL-C) ratio and incident cardiometabolic multimorbidity (CMM) among adults aged 50 years and older. Methods: This study analyzed data from wave 2 (2004) to wave 11 (2022) of the English Longitudinal Study of Ageing (ELSA) and wave 8 (2006) to wave 16 (2022) of the Health and Retirement Study (HRS). The independent variables included cumulative HbA1c/HDL-C ratio, its value at first visit, and its trajectory identified by group-based trajectory modeling (GBTM). The association between the HbA1c/HDL-C ratio and the risk of CMM was assessed using Kaplan–Meier curves, multivariable Cox regression analysis, and restricted cubic spline (RCS) models. Its incremental predictive value was also evaluated. Additionally, mediation analyses, subgroup analyses, and sensitivity analyses were further employed. Results: Among the 5,226 participants included, CMM developed in 303 of 1,918 participants (15.8%) in ELSA and in 283 of 3,308 participants (8.8%) in HRS. After adjusting for confounders, each 1-standard deviation (SD) increase in the cumulative HbA1c/HDL-C ratio and the value at first visit HbA1c/HDL-C ratio was significantly associated with a higher risk of CMM [pooled hazard ratio (HR): 1.33, 95% confidence interval (CI): 1.19–1.47, p < 0.001; pooled HR: 1.24, 95% CI: 1.07–1.43, p = 0.004]. Individuals in the persistently high HbA1c/HDL-C ratio group had a 100% higher risk of developing CMM than those in the persistently low group (pooled HR: 2.00, 95% CI: 1.45–2.74, p < 0.001). Linear associations were identified between the cumulative HbA1c/HDL-C ratio and incident CMM in ELSA and HRS, as well as between the HbA1c/HDL-C ratio and incident CMM at first visit in HRS (all p for overall <0.05 and p for non-linearity >0.05). The addition of the HbA1c/HDL-C ratio significantly improves the predictive ability of the basic model. The relationship between the trajectory of the HbA1c/HDL-C ratio and incident CMM was partially mediated by BMI in HRS. The results from sensitivity analyses and subgroup analyses aligned with the main findings. Conclusion: Significant linear associations were identified between increases in the HbA1c/HDL-C ratio and the risk of incident CMM among middle-aged and older adults from the United Kingdom (UK) and the United States (US). Persistent monitoring and maintenance of favorable levels of HbA1c/HDL-C ratio may contribute to the early detection and effective prevention of CMM development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnut.2026.1849520

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 57

  1. Miranda, 2019, Understanding the rise of cardiometabolic diseases in low- and middle-income countries, Nat Med, 25, 1667, 10.1038/s41591-019-0644-7 · DOI · Paper page
  2. Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, 52
  3. Cheng, 2022, Trends in the prevalence of Cardiometabolic multimorbidity in the United States, 1999-2018, Int J Environ Res Public Health, 19, 4726, 10.3390/ijerph19084726 · DOI
  4. Otieno, 2023, Cardiometabolic multimorbidity associated with moderate and severe disabilities: results from the study on global AGEing and adult health (SAGE) wave 2 in Ghana and South Africa, Glob Heart, 18, 9, 10.5334/gh.1188 · DOI
  5. Dove, 2023, Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry, Eur Heart J, 44, 573, 10.1093/eurheartj/ehac744 · DOI
  6. Dove, 2023, Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression, Alzheimers Dement, 19, 821, 10.1002/alz.12708 · DOI
  7. Huang, 2019, Cardiometabolic multimorbidity and depression in adults aged 45 years and older in China: longitudinal findings from the China health and retirement longitudinal study, Lancet, 394, S89, 10.1016/s0140-6736(19)32425-0 · doi:10.1016/s0140-6736(19)32425-0
  8. Canoy, 2021, Association between cardiometabolic disease multimorbidity and all-cause mortality in 2 million women and men registered in UK general practices, BMC Med, 19, 258, 10.1186/s12916-021-02126-x · DOI
  9. Liu, 2025, Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiometabolic multimorbidity among middle-aged and older adults in China, BMC Public Health, 25, 570, 10.1186/s12889-025-21757-w · DOI
  10. Liu, 2024, Association of Visceral Adiposity Index and Handgrip Strength with Cardiometabolic multimorbidity among middle-aged and older adults: findings from Charls 2011-2020, Nutrients, 16, 2277, 10.3390/nu16142277 · DOI
  11. Hu, 2021, Association between the plasma-glycosylated hemoglobin A1c/high-density lipoprotein cholesterol ratio and carotid atherosclerosis: a retrospective study, J Diabetes Res, 9238566, 10.1155/2021/9238566 · DOI
  12. He, 2024, The newly proposed plasma-glycosylated hemoglobin A1c/high-density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population, BMC Gastroenterol, 24, 274, 10.1186/s12876-024-03362-0 · DOI
  13. Wang, 2024, Correlation between glycolipid metabolism levels and diabetic retinopathy in patients with type 2 diabetes mellitus, DMSO, 17, 1, 10.2147/DMSO.S437586 · DOI
  14. Balintescu, 2019, Hemoglobin A1c and permissive hyperglycemia in patients in the intensive care unit with diabetes, Crit Care Clin, 35, 289, 10.1016/j.ccc.2018.11.010 · DOI
  15. Wan, 2016, Association of hemoglobin A1c levels with cardiovascular disease and mortality in Chinese patients with diabetes, J Am Coll Cardiol, 67, 456, 10.1016/j.jacc.2015.11.020 · doi:10.1016/j.jacc.2015.11.020
  16. Mineo, 2012, Novel biological functions of high-density lipoprotein cholesterol, Circ Res, 111, 1079, 10.1161/CIRCRESAHA.111.258673 · DOI · Paper page
  17. 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619 · DOI · Paper page
  18. Sonnega, 2014, Cohort profile: the health and retirement study (HRS), Int J Epidemiol, 43, 576, 10.1093/ije/dyu067 · DOI · Paper page
  19. Steptoe, 2013, Cohort profile: the English longitudinal study of ageing, Int J Epidemiol, 42, 1640, 10.1093/ije/dys168 · DOI · Paper page
  20. Dong, 2025, Association of HbA1c/HDL-C ratio and depression with cardiometabolic multimorbidity in middle-aged and older adults: a nationwide prospective cohort study, Front Nutr, 12, 1642243, 10.3389/fnut.2025.1642243 · DOI
  21. Huang, 2025, Association between the hemoglobin A1c/high-density lipoprotein cholesterol ratio and stroke incidence: a prospective nationwide cohort study in China, Lipids Health Dis, 24, 25, 10.1186/s12944-025-02438-4 · DOI
  22. Lu, 2025, Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study, Cardiovasc Diabetol, 24, 202, 10.1186/s12933-025-02754-0 · DOI
  23. Zhang, 2025, Association between the cumulative estimated glucose disposal rate and incident cardiovascular disease in individuals over the age of 50 years and without diabetes: data from two large cohorts in China and the United States, Cardiovasc Diabetol, 24, 51, 10.1186/s12933-025-02575-1 · DOI
  24. Lv, 2025, The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study, Cardiovasc Diabetol, 24, 358, 10.1186/s12933-025-02919-x · DOI
  25. Ruan, 2025, Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study, Cardiovasc Diabetol, 24, 382, 10.1186/s12933-025-02939-7 · DOI · Paper page
  26. Nagin, 2010, Group-based trajectory modeling in clinical research, Annu Rev Clin Psychol, 6, 109, 10.1146/annurev.clinpsy.121208.131413 · DOI · Paper page
  27. Yu, 2020, Association between visit-to-visit variability of HbA1c and cognitive decline: a pooled analysis of two prospective population-based cohorts, Diabetologia, 63, 85, 10.1007/s00125-019-04986-8 · DOI
  28. VanderWeele, 2017, Sensitivity analysis in observational research: introducing the E-value, Ann Intern Med, 167, 268, 10.7326/M16-2607 · DOI · Paper page
  29. Marco, 2025, Triglycerides to high density lipoprotein cholesterol ratio (TG/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes, Diabetes Res Clin Pract, 224, 112189, 10.1016/j.diabres.2025.112189 · DOI
  30. Mo, 2025, Cholesterol, high-density lipoprotein, and glucose index versus triglyceride–glucose index in predicting cardiovascular disease risk: a cohort study, Cardiovasc Diabetol, 24, 116, 10.1186/s12933-025-02675-y · DOI
  31. Ding, 2018, Hemoglobin A1c and diagnosis of diabetes, J Diabetes, 10, 365, 10.1111/1753-0407.12640 · DOI
  32. Mitsios, 2018, Relationship between glycated hemoglobin and stroke risk: A systematic review and Meta-analysis, J Am Heart Assoc, 7, e007858, 10.1161/JAHA.117.007858 · DOI
  33. Li, 2024, The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: a cohort study, Diabetes Res Clin Pract, 213, 111751, 10.1016/j.diabres.2024.111751 · DOI
  34. Khaw, 2006, Glycated hemoglobin as a marker of cardiovascular risk, Curr Opin Lipidol, 17, 637, 10.1097/mol.0b013e3280106b95 · DOI
  35. Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 · DOI · Paper page
  36. Chapman, 2006, Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease, Pharmacol Ther, 111, 893, 10.1016/j.pharmthera.2006.02.003 · DOI
  37. Castelli, 1986, Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study, JAMA, 256, 2835, 10.1001/jama.1986.03380200073024 · DOI · Paper page
  38. Chen, 2024, Differences in HDL-related coronary heart disease risk between individuals with and without diabetes, Atherosclerosis, 397, 118553, 10.1016/j.atherosclerosis.2024.118553 · DOI
  39. Amarenco, 2008, High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review, Atherosclerosis, 196, 489, 10.1016/j.atherosclerosis.2007.07.033 · DOI · Paper page
  40. Hu, 2023, The association between HDL-C and stroke in the middle-aged and elderly: A cross-sectional study, Brain Behav, 13, e2901, 10.1002/brb3.2901 · DOI
  41. Barter, 2007, HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events, N Engl J Med, 357, 1301, 10.1056/NEJMoa064278 · DOI · Paper page
  42. Kashyap, 2018, Glycation reduces the stability of ApoAI and increases HDL dysfunction in diet-controlled type 2 diabetes, J Clin Endocrinol Metab, 103, 388, 10.1210/jc.2017-01551 · DOI
  43. Zhou, 2025, Relationship of METS-IR with cardiometabolic multimorbidity in China: a nationwide longitudinal cohort study, Front Nutr, 12, 1518840, 10.3389/fnut.2025.1518840 · DOI
  44. Liu, 2025, Association between the CHG index and cardiometabolic multimorbidity: a nationwide prospective cohort and multi-community cross-sectional study, Front Nutr, 12, 1725495, 10.3389/fnut.2025.1725495 · DOI
  45. He, 2026, Association between the cumulative atherogenic index of plasma and cardiometabolic multimorbidity: the mediating effects of the TyG index and body mass index, Lipids Health Dis, 25, 65, 10.1186/s12944-026-02875-9 · DOI
  46. Zheng, 2025, Association between glycated hemoglobin/high-density lipoprotein ratio and nonalcoholic fatty liver disease in a U.S. nondiabetic population: a cross-sectional study based on NHANES 2017-2020 data, BMC Gastroenterol, 25, 567, 10.1186/s12876-025-04190-6 · DOI
  47. Wu, 2025, The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017-2020), BMC Gastroenterol, 25, 369, 10.1186/s12876-025-03974-0 · DOI
  48. Zeng, 2025, The association between HbA1c/HDL-C and the incidence of cardiometabolic multimorbidity in middle-aged and elderly adults: results from the China health and retirement longitudinal study, PLoS One, 20, e0332376, 10.1371/journal.pone.0332376 · DOI
  49. Hendriks, 2020, Alcohol and human health: what is the evidence?, Annu Rev Food Sci Technol, 11, 1, 10.1146/annurev-food-032519-051827 · DOI · Paper page
  50. Shi, 2017, Macro- and microvascular endothelial dysfunction in diabetes, J Diabetes, 9, 434, 10.1111/1753-0407.12521 · DOI · Paper page
  51. Sharma, 2024, Association of biomarkers for dyslipidemia, inflammation, and oxidative stress with endothelial dysfunction in obese youths: a case–control study, DMSO, 17, 2533, 10.2147/DMSO.S458233 · DOI
  52. Škrha, 2016, Glucose variability, HbA1c and microvascular complications, Rev Endocr Metab Disord, 17, 103, 10.1007/s11154-016-9347-2 · DOI
  53. Sun, 2025, Methylglyoxal mediates the association between 2-hour plasma glucose and HbA1c with inflammation: the Maastricht study, J Clin Endocrinol Metab, 110, 2047, 10.1210/clinem/dgae640 · DOI
  54. Adorni, 2021, High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives, Cells, 10, 574, 10.3390/cells10030574 · DOI
  55. Chen, 2022, Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy, J Mol Med, 100, 1721, 10.1007/s00109-022-02269-1 · DOI
  56. Silveira Rossi, 2022, Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors, Diabetes Metab Res Rev, 38, e3502, 10.1002/dmrr.3502 · DOI · Paper page
  57. Mr, 2005, Type 2 diabetes as a lipid disorder, Curr Mol Med, 5, 297, 10.2174/1566524053766086 · DOI · Paper page

Metadata

Authors
Ji, H., Zhao, Z., Li, R., Ma, W., Zhang, M., & Zhou, Z.
Venue
Frontiers in Nutrition
Published
2026-06-29
Volume
13
ISSN
2296-861X
Cited by
0
References
6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States. https://app.cochat.ai/papers/10.3389/fnut.2026.1849520
The paper
Ji, H., Zhao, Z., Li, R., Ma, W., Zhang, M., & Zhou, Z. (2026). The association between HbA1c/HDL-C ratio and cardiometabolic multimorbidity among middle-aged and older adults: data from two national prospective cohorts in the United Kingdom and United States. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2026.1849520

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.